2014
DOI: 10.1021/jz5019042
|View full text |Cite
|
Sign up to set email alerts
|

Plasmon-Enhanced Upconversion

Abstract: Upconversion, the conversion of photons from lower to higher energies, is a process that promises applications ranging from high-efficiency photovoltaic and photocatalytic cells to background-free bioimaging and therapeutic probes. Existing upconverting materials, however, remain too inefficient for viable implementation. In this Perspective, we describe the significant improvements in upconversion efficiency that can be achieved using plasmon resonances. As collective oscillations of free electrons, plasmon r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

2
223
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 261 publications
(227 citation statements)
references
References 108 publications
2
223
1
Order By: Relevance
“…The time‐resolved luminescence spectroscopy indicated that the lifetimes of 2 I 11/2 → 4 I 15/2 (521 nm), 4 S 3/2 → 4 I 15/2 (545 nm), and 4 F 9/2 – 4 I 15/2 (660 nm) decays for the NaYF 4 :Yb‐Er/W 18 O 49 film were shorter than the corresponding lifetimes obtained from the individual NaYF 4 :Yb‐Er film (Figure S7, Supporting Information). Combining with the results of selective luminescence enhancement, we confirmed the existence of plasmon‐mediated competition between the radiative and nonradiative processes in the NaYF 4 :Yb‐Er/W 18 O 49 film after 980 nm excitation 4, 7. The radiative rate enhancement is originated from the plasmon‐enhanced emission field, while the nonradiative process in the NaYF 4 :Yb‐Er/W 18 O 49 film is mainly attributed to the mentioned energy transfer.…”
supporting
confidence: 75%
See 3 more Smart Citations
“…The time‐resolved luminescence spectroscopy indicated that the lifetimes of 2 I 11/2 → 4 I 15/2 (521 nm), 4 S 3/2 → 4 I 15/2 (545 nm), and 4 F 9/2 – 4 I 15/2 (660 nm) decays for the NaYF 4 :Yb‐Er/W 18 O 49 film were shorter than the corresponding lifetimes obtained from the individual NaYF 4 :Yb‐Er film (Figure S7, Supporting Information). Combining with the results of selective luminescence enhancement, we confirmed the existence of plasmon‐mediated competition between the radiative and nonradiative processes in the NaYF 4 :Yb‐Er/W 18 O 49 film after 980 nm excitation 4, 7. The radiative rate enhancement is originated from the plasmon‐enhanced emission field, while the nonradiative process in the NaYF 4 :Yb‐Er/W 18 O 49 film is mainly attributed to the mentioned energy transfer.…”
supporting
confidence: 75%
“…This is mainly due to their unique capability to concentrate and amplify the incident light intensity near the surface of plasmonic nanostructures 1, 2, 3. As a classic plasmonic “optical antenna,” noble metal nanostructures with tunable LSPR energy are frequently introduced into nanomaterials to promote their performance in light absorption and/or emission via plasmonic energy transfer from noble metal to neighboring optical nanomaterials 4, 5, 6. For example, coupling appropriate nanostructures of plasmonic Au or Ag with upconversion nanomaterials, in particular trivalent lanthanide ions (Ln 3+ )‐doped NaYF 4 nanoparticles (NPs), can achieve enhanced upconversion luminescence in the visible light region by converting lower frequency incident photons at 980 nm with high effectivity 7, 8, 9.…”
mentioning
confidence: 99%
See 2 more Smart Citations
“…Thus far, photon UC has been utilized in various applications such as IR quantum counters, solid-state lasers, in lighting, displays, and solar cells [4][5][6]. In recent years, the successful synthesis of colloidally stable solutions of monodisperse upconverting nanoparticles (UCNPs) with diameters on the order and less than 50 nm has opened up new opportunities in this general area [7][8][9]. It is envisioned that such UCNPs may replace dye molecules as diagnostic and therapeutic tools for biological imaging, or can be used in targeted drug delivery [10][11][12].…”
Section: Introductionmentioning
confidence: 99%